These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
127 related items for PubMed ID: 3864207
1. Assessment of the pyrogenic potency of the thromboxane A2-mimetics, SQ26655 and U46619, and thromboxane B2 by intrapreoptic injection in the cat. Gollman HM, Rudy TA. Res Commun Chem Pathol Pharmacol; 1985 Aug; 49(2):305-8. PubMed ID: 3864207 [Abstract] [Full Text] [Related]
2. Thromboxane agonism and antagonism in a mouse sudden death model. Myers A, Penhos J, Ramey E, Ramwell P. J Pharmacol Exp Ther; 1983 Feb; 224(2):369-72. PubMed ID: 6822961 [Abstract] [Full Text] [Related]
4. Comparative pyrogenic potency of endogenous prostanoids and of prostanoid-mimetics injected into the anterior hypothalamic/preoptic region of the cat. Gollman HM, Rudy TA. Brain Res; 1988 May 24; 449(1-2):281-93. PubMed ID: 3395849 [Abstract] [Full Text] [Related]
5. Kinetics of prostaglandin E2 and thromboxane A2 synthesis and suppression of PHA-stimulated peripheral blood mononuclear leucocytes. Awara W, Hillier K, Jones D. Immunology; 1986 Dec 24; 59(4):557-62. PubMed ID: 3468061 [Abstract] [Full Text] [Related]
6. U46619 (a thromboxane A2 mimetic) induces airflow obstruction and airway plasma extravasation in the guinea pig: the role of histamine, cyclooxygenase metabolites, leukotrienes and PAF. Kawikova I, Arakawa H, Skoogh BE, Löfdahl CG, Lötvall J. J Pharmacol Exp Ther; 1996 Jul 24; 278(1):268-76. PubMed ID: 8764360 [Abstract] [Full Text] [Related]
7. Effects of thromboxane agonists on cardiac adrenergic neurotransmission. Mantelli L, Amerini S, Rubino A, Ledda F. Eur J Pharmacol; 1992 Mar 17; 213(1):79-85. PubMed ID: 1323473 [Abstract] [Full Text] [Related]
8. Thromboxane A2 analogues inhibit the metabolism of thromboxane B2 in perfused guinea-pig lung. Robinson C, Hoult JR. Biochim Biophys Acta; 1983 Nov 29; 754(2):190-200. PubMed ID: 6652102 [Abstract] [Full Text] [Related]
9. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation. Meja KK, Barnes PJ, Giembycz MA. Br J Pharmacol; 1997 Sep 29; 122(1):149-57. PubMed ID: 9298541 [Abstract] [Full Text] [Related]
10. Selective inhibition of thromboxane B2 accumulation and metabolism in perfused guinea-pig lung. Hoult JR, Robinson C. Br J Pharmacol; 1983 Jan 29; 78(1):85-8. PubMed ID: 6824820 [Abstract] [Full Text] [Related]
11. Thromboxane and stable prostaglandin endoperoxide analogs stimulate water permeability in the toad urinary bladder. Burch RM, Halushka PV. J Clin Invest; 1980 Dec 29; 66(6):1251-7. PubMed ID: 6777398 [Abstract] [Full Text] [Related]
12. Activation of endogenous thromboxane A2 biosynthesis mediates presynaptic inhibition by endothelin-3 of dog stellate ganglionic transmission. Kushiku K, Ohjimi H, Yamada H, Kuwahara T, Furukawa T. J Pharmacol Exp Ther; 1995 Jan 29; 272(1):70-6. PubMed ID: 7815366 [Abstract] [Full Text] [Related]
13. Pulmonary pharmacology of DT-TX 30 SE, a potent selective combined thromboxane synthetase inhibitor and receptor antagonist, in guinea pigs. Meade CJ, Muacevic G, Ward P, Soyka R. Jpn J Pharmacol; 1996 Jun 29; 71(2):119-27. PubMed ID: 8835638 [Abstract] [Full Text] [Related]
14. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets. Jin YR, Cho MR, Lee KS, Lee JJ, Lim Y, Han XH, Oh KW, Hong JT, Yoo HS, Yun YP. Basic Clin Pharmacol Toxicol; 2005 Sep 29; 97(3):162-7. PubMed ID: 16128910 [Abstract] [Full Text] [Related]